Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 USD | +10.42% |
|
+20.98% | -21.95% |
Jun. 26 | Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Jun. 11 | Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.95% | 243M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- CYBN Stock
- News Cybin Inc.
- Transcript : Cybin Inc. Presents at Canaccord Genuity 42nd Annual Growth Conference, Aug-11-2022 03